Related Experiment Video
Updated: May 24, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Transforming regulatory science 2012: making a difference
1Office of the Chief Scientist/Office of the Commissioner, US Food and Drug Administration, Department of Health and Human Services, Silver Spring, Maryland, USA. jesse.goodman@fda.hhs.gov
Abstract:
"What does not change is the will to change."-Charles Olson, "The Kingfishers"The world is in the midst of scientific revolutions that can transform medicine and public health. Yet translation to needed products remains slow and expensive. There are major opportunities for new regulatory science to help transform product development and evaluation. A plan by the US Food and Drug Administration (FDA), "Advancing Regulatory Science," identifies eight priorities and numerous actions to help catalyze transformation. Scientific excellence and collaboration, including public and private sectors, are essential for change that benefits health and economies globally.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Global Regulatory Systems
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Regulation
Translational Regulation
Positive Regulator Molecules

